Malvin Sjo

Subcutaneous Recombinant Hirudin (HBW 023) Versus Intravenous Sodium Heparin in Treatment of Established Acute Deep Vein Thrombosis of the Legs: a Multicentre Prospective Dose-ranging Randomized Trial

François Schiele, Folke Lindgaerde, Henry Eriksson et al. · Thrombosis and Haemostasis · 1997 · 85 citations

Thrombosis, Venous Disease, Venous Thrombosis +15

Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia

�ystein Wendelbo, Ingerid Nesthus, Malvin Sjo et al. · Cancer Immunology Immunotherapy · 2004 · 56 citations · Full text

Hematological Malignancy, Mixed-phenotype Acute Leukemia, Malignant Blood Disorder +10

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Astrid Gruber, Magnus Björkholm, L Brinch et al. · Leukemia Research · 2003 · 35 citations

Hematological Malignancy, Psc 833, Phase I/ii Study +10

The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications

Håkon Reikvam, Knut Anders Mosevoll, Guro Kristin Melve et al. · Biology of Blood and Marrow Transplantation · 2011 · 34 citations · Full text

Healthy Individuals, Posttransplantation Complications, Immunology +18

Early pre-engraftment, functional, in vitro responsiveness of T lymphocytes in allotransplanted, acute leukemia patients: proliferation and release of a broad profile of cytokines, possibly predictive of graft-versus-host disease

Knut Liseth, Malvin Sjo, Kristin Paulsen et al. · European Cytokine Network · 2010 · 13 citations

Cell Therapy, T-regulatory Cell, Immunology +19